These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12455304)

  • 1. Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from i.v. to oral.
    Kuti JL; Le TN; Nightingale CH; Nicolau DP; Quintiliani R
    Am J Health Syst Pharm; 2002 Nov; 59(22):2209-15. PubMed ID: 12455304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and economic impact of a pharmacist-managed i.v.-to-p.o. conversion service for levofloxacin in Taiwan.
    Yen YH; Chen HY; Wuan-Jin L; Lin YM; Shen WC; Cheng KJ
    Int J Clin Pharmacol Ther; 2012 Feb; 50(2):136-41. PubMed ID: 22257579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a physician order entry system to identify opportunities for intravenous to oral levofloxacin conversion.
    Glemaud I
    Am J Health Syst Pharm; 2000 Nov; 57 Suppl 3():S14-6. PubMed ID: 11098315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of length of stay, total costs, and treatment success between intravenous moxifloxacin 400 mg and levofloxacin 750 mg among hospitalized patients with community-acquired pneumonia.
    Friedman H; Song X; Crespi S; Navaratnam P
    Value Health; 2009; 12(8):1135-43. PubMed ID: 19695010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacist-initiated program of intravenous to oral antibiotic conversion.
    Przybylski KG; Rybak MJ; Martin PR; Weingarten CM; Zaran FK; Stevenson JG; Levine DP
    Pharmacotherapy; 1997; 17(2):271-6. PubMed ID: 9085318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia.
    Clark LC; Davis CW
    Am J Health Syst Pharm; 2000 Nov; 57 Suppl 3():S10-3. PubMed ID: 11098314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An economic evaluation of levofloxacin versus cefuroxime axetil in the outpatient treatment of adults with community-acquired pneumonia.
    Rittenhouse BE; Stinnett AA; Dulisse B; Henke CJ; Potter L; Parasuraman B; Martens LL; Williams RR; Kojak C
    Am J Manag Care; 2000 Mar; 6(3):381-9. PubMed ID: 10977438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to drug therapy, formulary, and pathway management in a large community hospital.
    Halley HJ
    Am J Health Syst Pharm; 2000 Nov; 57 Suppl 3():S17-21. PubMed ID: 11098316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia.
    File TM; Milkovich G; Tennenberg AM; Xiang JX; Khashab MM; Zadeikis N
    Curr Med Res Opin; 2004 Sep; 20(9):1473-81. PubMed ID: 15383197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full-course oral levofloxacin for treatment of hospitalized patients with community-acquired pneumonia.
    Erard V; Lamy O; Bochud PY; Bille J; Cometta A; Calandra T
    Eur J Clin Microbiol Infect Dis; 2004 Feb; 23(2):82-8. PubMed ID: 14727149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous-to-oral transition therapy in community-acquired pneumonia: the INOVA Health System experience.
    Milkovich G
    Pharmacotherapy; 2001 Jul; 21(7 Pt 2):83S-88S. PubMed ID: 11446523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of therapeutic interchange with standard educational tools for influencing fluoroquinolone prescribing.
    Goldwater SH; Milkovich G; Morrison AJ; Lindgren B
    Am J Health Syst Pharm; 2001 Sep; 58(18):1740-5. PubMed ID: 11571817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial.
    Samsa GP; Matchar DB; Harnett J; Wilson J
    Chest; 2005 Nov; 128(5):3246-54. PubMed ID: 16304269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is the switch of fluoroquinolones from intravenous to oral administration useful in an intensive care unit? Economical approach].
    Turc J; Eve O; Tran Van D; Wey PF; Martinez JY
    Ann Fr Anesth Reanim; 2009 Feb; 28(2):179-80. PubMed ID: 19171451
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study on the efficacy of levofloxacin and ceftazidime in acute exacerbation of bronchiectasis.
    Tsang KW; Chan WM; Ho PL; Chan K; Lam WK; Ip MS
    Eur Respir J; 1999 Nov; 14(5):1206-9. PubMed ID: 10596714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
    Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT;
    Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
    Martinez FJ; Grossman RF; Zadeikis N; Fisher AC; Walker K; Ambruzs ME; Tennenberg AM
    Eur Respir J; 2005 Jun; 25(6):1001-10. PubMed ID: 15929954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness comparison of sequential ofloxacin versus standard switch therapy.
    Partsch DJ; Paladino JA
    Ann Pharmacother; 1997 Oct; 31(10):1137-45. PubMed ID: 9337437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist-driven antimicrobial stewardship program in an institution without infectious diseases physician support.
    Waters CD
    Am J Health Syst Pharm; 2015 Mar; 72(6):466-8. PubMed ID: 25736941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.